# Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas

> **NCT05392374** · — · NO_LONGER_AVAILABLE · sponsor: **Jazz Pharmaceuticals**

## Conditions studied

- Glioma

## Interventions

- **DRUG:** ONC201

## Key facts

- **NCT ID:** NCT05392374
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2022-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05392374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05392374, "Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05392374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*